Endogenous opiates, opioids, and immune function: Evolutionary brokerage of defensive behaviors

Seminars in Cancer Biology

Volumn 18, Issue 3, 2008, Pages 190-198

  Stefano, George B ^a   Kream, Richard ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cancer; Chemokine; Enkelytin; Morphine; Nitric oxide

Indexed keywords

ALPHA INTERMEDIN; ALPHA NEOENDORPHIN; CATECHOLAMINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CORTICOTROPIN; DYNORPHIN A; DYNORPHIN B; ENKEPHALIN; G PROTEIN COUPLED RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NEUROPEPTIDE; NITRIC OXIDE; OPIATE; OPIATE PEPTIDE; PRODYNORPHIN; PROENKEPHALIN; PROOPIOMELANOCORTIN;

BACTERICIDAL ACTIVITY; BIOSYNTHESIS; CHEMOTAXIS; CYTOKINE RELEASE; DEFENSIVE BEHAVIOR; HUMAN; IMMUNE SYSTEM; IMMUNOREACTIVITY; INVERTEBRATE; LYMPHOCYTE; MORPHOGENESIS; NOCICEPTION; REVIEW; SEQUENCE HOMOLOGY;

ANALGESICS, OPIOID; ANIMALS; HUMANS; IMMUNE SYSTEM; MORPHINE; OPIOID PEPTIDES; PAIN;

EID: 42649127050     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2007.12.001     Document Type: Review

References (91)

1. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K., Magazine H.I., Bilfinger T.V., et al. Opioid and opiate immunoregulatory processes. Crit Rev Immunol 16 (1996) 109-144
2. Stefano G.B., Melchiorri P., Negri L., Hughes T.K., and Scharrer B. (d-Ala2)-Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc Natl Acad Sci USA 89 (1992) 9316-9320
3. Shipp M.A., Stefano G.B., D'Adamio L., Switzer S.N., Howard F.D., Sinisterra J.I., et al. Downregulation of enkephalin-mediated inflammatory response by CD10/neutral endopeptidase 24.11. Nature 347 (1990) 394-396
4. Leung M.K., and Stefano G.B. Isolation and identification of enkephalin in pedal ganglia of Mytilus edulis (mollusca). Proc Natl Acad Sci USA 81 (1984) 955-958
5. Stefano G.B., and Leung M.K. Presence of met-enkephalin-Arg6-Phe7 in molluscan neural tissues. Brain Res 298 (1984) 362-365
6. Luschen W., Buck F., Willig A., and Jaros P.P. Isolation, sequence analysis, and physiological properties of enkephalins in the nervous tissue of the shore crab, Carcinus maenas L. Proc Natl Acad Sci USA 88 (1991) 8671-8675
7. Rothe H., Luschen W., Asken A., Willig A., and Jaros P.P. Purified crustacean enkephalins inhibits release of hyperglycemic hormone in the crab, Carcinus maenas L. Comp Biochem Physiol 99C (1991) 57-62
8. Ewandinger N.M., Ridgway R.L., Syed N.I., Lukowiak K., and Bulloch A.G.M. Identification and localization of a (Met5)-enkephalin-like peptide in the mollusc, Lymnaea stagnalis. Brain Res 737 (1996) 1-15
9. Salzet M., Bulet P., Verger-Bocquet M., and Malecha J. Isolation and structural characterization of enkephalin-related peptides in the brain of the Rhynchobdellid leech Theromyzon tessulatum. FEBS Lett 357 (1995) 187-191
10. Salzet M., Verger-Bocquet M., Bulet P., Beauvillain J.C., and Malecha J. Purification, sequence analysis and cellular localization of a prodynorphin-derived peptide related to the α neo-endorphin in the rhynchobdellid leech Theromyzon tessulatum. J Biol Chem 271 (1996) 13191-13196
11. Salzet M., and Stefano G.B. Prodynorphin in invertebrates. Mol Brain Res 52 (1997) 46-52
12. Salzet M., and Stefano G.B. Invertebrate proenkephalin: delta opioid binding sites in leech ganglia and immunocytes. Brain Res 768 (1997) 224-232
13. Salzet M., Cocquerelle C., Verger-Bocquet M., Pryor S.C., Rialas C.M., Laurent V., et al. Leech immunocytes contain proopiomelanocortin: nitric oxide mediates hemolymph POMC processing. J Immunol 159 (1997) 5400-5411
14. Goumon Y., Strub J.M., Moniatte M., Nullans G., Poteur L., Hubert P., et al. The C-terminal biophosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity. Eur J Biochem 235 (1996) 516-525
15. Brix-Christensen V., Tonnesen E., Sanchez R.G., Bilfinger T.V., and Stefano G.B. Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response?. Int J Cardiol 62 (1997) 191-197
16. Stefano G.B., Salzet B., and Fricchione G.L. Enkelytin and opioid peptide association in invertebrates and vertebrates: immune activation and pain. Immunol Today 19 (1998) 265-268
17. Salzet M., Salzet B., Tasiemski A., Goumon Y., Metz M.H., Aunis D., et al. LPS and surgical trauma increase enkephalin and enkelytin levels in invertebrate hemoplymph: processing by neutral endopeptidase. Mol Brain Res 76 (1998) 237-252
18. Chapman C.R. Pain: the perception of noxious events. In: Sternbach R.A. (Ed). The psychology of pain (1978), Raven Press, New York 169-202
19. Reisine T., and Pasternak G.W. Opioid analgesics and antagonists. In: Hardman J.G., and Limbird L.E. (Eds). The pharmacological basis of therapeutics (1996), McGraw Hill, New York 521-556
20. Stein C., Hassan A.H., Lehrberger K., Giefing J., and Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 342 (1993) 321-324
21. Esch T., and Stefano G.B. The neurobiology of pleasure, reward processes, addiction and their health implications. Neuroendocrinol Lett 25 (2004) 235-251
22. Esch T., and Stefano G.B. The Neurobiology of Love. Neuroendocrinol Lett 26 (2005) 175-192
23. Turner A., Leung M.K., and Stefano G.B. Peptidases of significance in neuroimmunoregulation. In: Scharrer B., Smith E.M., et al. (Eds). Neuropeptides in neuroimmunology (1994), Springer-Verlag 152-169
24. Duvaux-Miret O., Stefano G.B., Smith E.M., Dissous C., and Capron A. Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of immunoactive neuropeptides. Proc Natl Acad Sci USA 89 (1992) 778-781
25. Smith E.M., Hughes T.K., Hashemi F., and Stefano G.B. Immunosuppressive effects of ACTH and MSH and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA 89 (1992) 782-786
26. Shipp M.A., Stefano G.B., Switzer S.N., Griffin J.D., and Reinherz E. CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood 78 (1991) 1834-1841
27. Fricchione G.L., Bilfinger T.V., Jandorf L., Smith E.M., and Stefano G.B. Surgical anticipatory stress manifests itself in immunocyte desensitization: evidence for autoimmunoregulatory involvement. Int J Cardiol 53 (1996) S65-S74
28. Gintzler A.R., Levy A., and Spector S. Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide morphine-like compound in the central nervous system. Proc Natl Acad Sci USA 73 (1976) 2132-2136
29. Kream R.M., and Stefano G.B. De novo biosynthesis of morphine in animal cells: an evidence-based model. Med Sci Monit 12 (2006) RA207-RA219
30. Zhu W., Mantione K.J., Shen L., Cadet P., Esch T., Goumon Y., et al. Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med Sci Monit 11 (2005) BR397-BR404
31. Zhu W., Cadet P., Baggerman G., Mantione K.J., and Stefano G.B. Human white blood cells synthesize morphine: CYP2D6 modulation. J Immunol 175 (2005) 7357-7362
32. Poeaknapo C., Schmidt J., Brandsch M., Drager B., and Zenk M.H. Endogenous formation of morphine in human cells. Proc Natl Acad Sci USA 101 (2004) 14091-14096
33. Stefano G.B., Digenis A., Spector S., Leung M.K., Bilfinger T.V., Makman M.H., et al. Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci USA 90 (1993) 11099-11103
34. Lord J.A.H., Waterfield A.A., Hughes J., and Kosterlitz H.W. Endogenous opioid peptodes: multiple agonists and receptors. Nature 267 (1977) 495-499
35. Pasternak G.W. The Opiate Receptors (1988), Humana Press, New Jersey
36. Stefano G.B., Leung M.K., Zhao X., and Scharrer B. Evidence for the involvement of opioid neuropeptides in the adherence and migration of immunocompetent invertebrate hemocytes. Proc Natl Acad Sci USA 86 (1989) 626-630
37. Stefano G.B., Cadet P., and Scharrer B. Stimulatory effects of opioid neuropeptides on locomotory activity and conformational changes in invertebrate and human immunocytes: evidence for a subtype of delta receptor. Proc Natl Acad Sci USA 86 (1989) 6307-6311
38. Cadet P., Mantione K.J., and Stefano G.B. Molecular identification and functional expression of mu3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol 170 (2003) 5118-5123
39. Cantacuzene J. Nouvelles recherches sur led mode de destruction des vibrions dans l'organisme. Ann Inst Pasteur 12 (1898) 273-300
40. Archard C., Bernard H., and Gagneux C. Action de la morphine sur les proprietes leucocytaires: leuco-diagnostic du morphinisme. Bull Mem Soc Med Hosp Paris 28 (1909) 958
41. Tubaro E., Borelli G., Croce C., Cavallo G., and Santiangeli C. Effect of morphine on resistance to infection. J Infect Dis 148 (1983) 656-666
42. Weber R.J., Band L.C., DeCosta B., Pert A., and Rice K.C. Neural control of immune function: opioids, opioid receptors and immunosuppression. NIDA Res Monogr 105 (1991) 96-102
43. Perez-Castrillon J.P., Perez-Arellano J.P., Garcia-Palomo J.D., Jimenez-Lopez A., and DeCastro S. Opioids depress in vitro human monocyte chemotaxis. Immunopharmacol 23 (1992) 57-61
44. Stefano G.B., and Bilfinger T.V. Human neutrophil and macrophage chemokinesis induced by cardiopulmonary bypass: loss of DAME and IL-1 chemotaxis. J Neuroimmunol 47 (1993) 189-198
45. Stefano G.B. Pharmacological and binding evidence for opioid receptors on vertebrate and invertebrate blood cells. In: Scharrer B., Smith E.M., et al. (Eds). Neuropeptides and Immunoregulation (1994), Springer-Verlag p. 139-151
46. Malfroy B., Swerts J.P., Guyon A., Roques B.P., and Schwartz J.C. High affinity enkephalin degrading peptidase in brain is increased after morphine. Nature 276 (1978) 523-526
47. Wybran J., Appelboom T., Famaey J.P., and Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol 123 (1979) 1068-1070
48. McDonough R.J., Madden J.J., Falek A., Shafer D.A., Pline M., Gordon D., et al. Alteration of T- and null-lymphocyte frequences in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T-lymphocytes. J Immunol 125 (1980) 2539-2543
49. Miller G.C., Murgo A.J.R., and Plotnikoff N.P. Enkephalins-enhancement of active T-cell rosettes from lymphoma patients. Clin Immunol Immunopathol 26 (1983) 446-451
50. Scharrer B., and Stefano G.B. Neuropeptides and autoregulatory immune processes. In: Scharrer B., Smith E.M., et al. (Eds). Neuropeptides and immunoregulation (1994), Springer-Verlag p. 1-18
51. Stefano G.B., and Scharrer B. Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol 4 (1994) 57-68
52. Donahoe R.M. Neuroimmunomodulation by opiates: relationship to HIV-1 infection and AIDS. Adv Neuroimmunol 3 (1993) 31-46
53. Donahoe R.M., Byrd L.D., McClure H.M., Fultz P., Brantley M., Marsteller F., et al. Consequences of opiate dependency in a monkey model of AIDS. Adv Exp Med Biol 335 (1993) 21-28
54. Peterson P.K., Sharp B.M., Gekker G., Brummitt C., and Keane W.F. Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol 138 (1987) 3907-3912
55. Eisenberg R.M. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists. J Pharmacol Exp Ther 233 (1985) 863-869
56. Nikolarakis K.E., Pfeiffer A., Stalla G., and Herz A. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats. Brain Res 421 (1987) 373-376
57. Bryant H.U., Bernton E.W., and Holaday J.W. Morphine-induced immunosuppression: Involvement of glucocorticoids and prolactin. NIDA Res Monogr 90 (1988) 323
58. Flores C.M., Hernandez M.C., Hargreaves K.M., and Bayer B.M. Restraint stress-induced elevations in plasma corticosterone and β-endorphin are not accompanied by alterations in immune function. J Neuroimmunol 28 (1990) 219-225
59. Smith E.M., Hughes T.K., Cadet P., and Stefano G.B. CRF induced immunosuppression in human and invertebrate immunocytes. Cell Mol Neurobiol 12 (1992) 473-482
60. Goumon Y., Muller A., Glattard E., Marban C., Gasnier C., Strub J.M., et al. Identification of morphine-6-glucuronide in chromaffin cell secretory granules. J Biol Chem 281 (2006) 8082-8089
61. Howard M., O'Garra A., Ishida H., de Waal Malefy T.R., and De Vries J. Biological properties of interleukin 10. J Clin Immunol 12 (1992) 239-248
62. Moore K.W., O'Garra A., de Waal Malefy T.R., Vieira P., and Mosmann T.R. Interleukin-10. Ann Rev Immunol 11 (1993) 165-190
63. Bilfinger T.V., Fricchione G.L., and Stefano G.B. Neuroimmune implications of cardiopulmonary bypass. Adv Neuroimmunol 3 (1993) 277-288
64. Bilfinger T.V., and Stefano G.B. Evidence of immunocyte stimulatory molecules(s) in plasma of patients undergoing cardiopulmonary bypass. J Cardiovasc Surg 34 (1993) 129-133
65. Stefano G.B. Autoimmunovascular regulation: morphine and anandamide stimulated nitric oxide release. J Neuroimmunol 83 (1998) 70-76
66. Donnerer J., Cardinale G., Coffey J., Lisek C.A., Jardine I., and Spector S. Chemical characterization and regulation of endogenous morphine and codeine in the rat. J Pharmacol Exp Ther 242 (1987) 583-587
67. Lee C.S., and Spector S. Changes of endogenous morphine and codeine contents in the fasting rat. J Pharmacol Exp Ther 257 (1991) 647-650
68. Molina P.E., Hashiguchi Y., Meijerink W.J.H.J., Naukam R.J., Boxer R., and Abumrad N.N. Modulation of endogenous opiate production: effect of fasting. Biochem Biophys Res Commun 207 (1995) 312-317
69. Ottaviani E., Franchini A., Sonetti D., and Stefano G.B. Antagonizing effect of morphine on the mobility and phagocytic activity of invertebrate immunocytes. Eur J Pharmacol 276 (1995) 35-39
70. Stefano G.B., Leung M.K., Bilfinger T.V., and Scharrer B. Effect of prolonged exposure to morphine on responsiveness of human and invertebrate immunocytes to stimulatory molecules. J Neuroimmunol 63 (1995) 175-181
71. Bilfinger T.V., Kushnerik V., Bundz S., Liu Y., and Stefano G.B. Evidence for morphine downregulating immunocytes during cardiopulmonary bypass in a porcine model. Int J Cardiol 53 (1996) S39-S46
72. Liu Y., Shenouda D., Bilfinger T.V., Stefano M.L., Magazine H.I., and Stefano G.B. Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res 722 (1996) 125-131
73. Stefano G.B., and Liu Y. Opiate antagonism of opioid actions on immunocyte activation and nitric oxide release. Anim Biol 1 (1996) 11-16
74. Stefano G.B., Goumon Y., Bilfinger T.V., Welters I., and Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. Prog Neurobiol 60 (2000) 513-530
75. Welters I.D., Menzebach A., Goumon Y., Langefeld T.W., Teschemacher H., Hempelmann G., et al. Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism. J Neuroimmunol 111 (2000) 139-145
76. Welters I.D., Menzebach A., Goumon Y., Cadet P., Menges T., Hughes T.K., et al. Morphine inhibits NF-κB nuclear binding in human neutrophils and monocytes by a nitric oxide dependent mechanism. Anesthesiology 92 (2000) 1677-1684
77. Stefano G.B., and Benz D. Nitric oxide modulates cell shape. Curr Opin Eur Med 3 (2002) 32-39
78. Stefano G.B., Salzet M., and Magazine H.I. Cyclic nitric oxide release by human granulocytes, and invertebrate ganglia and immunocytes: nano-technological enhancement of amperometric nitric oxide determination. Med Sci Monit 8 (2002) BR199-BR204
79. Magazine H.I., Chang J., Goumon Y., and Stefano G.B. Rebound from nitric oxide inhibition triggers enhanced monocyte activation and chemotaxis. J Immunol 165 (2000) 102-107
80. Stefano G.B., Salzet M., Magazine H.I., and Bilfinger T.V. Antagonist of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 31 (1998) 813-820
81. Stefano G.B., Salzet M., Rialas C., Mattocks D.W., Fimiani C., and Bilfinger T.V. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. Int J Cardiol 64 (1998) S3-S13
82. Stefano G.B., Neenan K., Cadet P., Magazine H.I., and Bilfinger T.V. Ischemic preconditioning-an opiate constitutive nitric oxide molecular hypothesis. Med Sci Monit 7 (2001) 1357-1375
83. Stefano G.B., and Kream R.M. Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (review). Int J Mol Med 20 (2007) 837-841
84. Cadet P., Mantione K.J., Zhu W., Kream R.M., Sheehan M., and Stefano G.B. A functionally coupled mu3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells. J Immunol 179 (2007) 5839-5844
85. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., and Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the OPRM gene. Proc Nat Acad Sci USA 98 (2001) 14084-14089
86. Doyle G.A., Rebecca S.X., Lin S.S., Press D.M., Grice D.E., Buono R.J., et al. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon. Gene 388 (2007) 135-147
87. Venkatesan S., Petrovic A., Locati M., Kim Y.O., Weissman D., and Murphy P.M. A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression. J Biol Chem 276 (2001) 40133-40145
88. Tummala M., Ryzhov V., Ravi K., and Black S.M. Identification of the cysteine nitrosylation sites in human endothelial nitric oxide synthase. DNA Cell Biol (2007)
89. Iwakiri Y., Satoh A., Chatterjee S., Toomre D.K., Chalouni C.M., Fulton D., et al. Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc Natl Acad Sci USA 103 (2006) 19777-19782
90. Stefano G.B., Kream R.M., Mantione K.J., Sheehan M., Cadet P., Zhu W., et al. Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology. Sem Cancer Biol 18 (2008) 199-210
91. Kream R.M., Sheehan M., Cadet P., Mantione K.J., Zhu W., Casares F.M., et al. Persistence of evolutionary memory: primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling. Med Sci Monit 13 12 (2007) SC5-SC6